Boericke took over one of Central Massachusetts’ most significant life sciences service companies at a pivotal moment for the drug-development industry. Named Veristat’s first female CEO in January, she quickly reshaped the company’s strategy, completed a $135-million acquisition, expanded international operations, and launched AI-powered tools that reduced some analytical workflows from five to seven weeks to five days or less. Her broader goal is equally ambitious: helping pharmaceutical companies bring life-saving therapies to market faster and at lower cost.
What unique skill sets you apart from others? I take a bird’s-eye view to address challenges strategically, then dive into the details to execute. I can see the big picture while understanding the nuance.
What is one habit powerful leaders should practice every day? The best leaders stay present and listen carefully. It provides the perspective needed to either step up and lead or create space for others to do so.
Why do you do business in Central Mass.? The heart of biotech sits in Massachusetts. It’s a prime place to find innovative companies and support drug-development programs.
How do you unwind? Pilates, reading, and cooking.
